After deliberating for five hours, a Philadelphia jury yesterday came back with an $8 million verdict against the manufacturer of fenfluramine, the fen in the fen-phen diet drug combination, and a doctor who prescribed it to a popular jazz musician who developed primary pulmonary hypertension from taking it.
Jazz artist Shirley Scott settled with American Home Products for an undisclosed amount of money before the start of the trial. Defendant Dr. Leonard Guinta filed a cross-claim against American Home.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]